Abstract
Maggot debridement therapy (MDT) was first introduced in the US in 1931 and was routinely used here until mid-1940s in over 300 hospitals. With the advent of antibacterials, maggot therapy became rare until the early 1990s, when it was re-introduced first in the US, and later in Israel, the UK, Germany, Sweden, Switzerland, Ukraine and Thailand.
Sterile maggots of the green bottle fly, Lucilia (Phaenicia) sericata, are used for MDT. Up to 1000 maggots are introduced in the wound and left for 1 to 3 days. MDT could be used for any kind of purulent, sloughy wound on the skin, independent of the underlying diseases or the location on the body for ambulatory as well as for hospitalized patients. One of the major advantages of MDT is that the maggots separate the necrotic tissue from the living tissue, making a surgical debridement easier. In 80 to 95% of the cases, a complete or significant debridement of the wound is achieved. As therapy progresses, new layers of healthy tissue are formed over the wounds. The offensive odor emanating from the necrotic tissue and the intense pain accompanying the wound decrease significantly. In a significant number of patients, an immediate amputation can be prevented as a result of MDT. In other cases, a more proximal amputation could be avoided. It is also possible that in patients with deep wounds, where septicemia is a serious threat, this can be prevented as a result of MDT.
The majority of patients do not complain of any major discomfort during the treatment. Psychological and esthetic considerations are obvious. Maggots can occasionally cause a tickling or itching sensation. Approximately 20 to 25% of the patients with superficial, painful wounds, complain of increased pain during treatment with maggots, and are treated with analgesics.
MDT has been proven to be an effective method for cleaning chronic wounds and initiating granulation. It is a simple, efficient, well tolerated and cost-effective tool for the treatment of wounds and ulcers, which do not respond to conventional treatment and surgical intervention.
Similar content being viewed by others
References
Chernin E. Surgical maggots. South Med J 1986; 79: 1143–1145
Baer W.S. The treatment of chronic osteomyelitis with the maggot (larva of the blow fly). J Bone Joint Surg 1931; 13: 438–475
McKeever D.C. Maggots in treatment of osteomyelitis. J Bone Joint Surg 1933; 15: 85–93
Robinson W., Norwood V.H. The role of surgical maggots in the disinfection of osteomyelitis and other infected wounds. J Bone Joint Surg 1933; 15: 409–412
Sherman R.A., Pechter E.A. Maggot therapy: a review of the therapeutic application of fly larvae in human medicine, especially for treating osteomyelitis. Med Vet Entomol 1988; 2: 225–230
Horn K.L., Cobb A.H., Gates G.A. Maggot therapy for subacute mastoiditis. Arch Otolaryngol 1976; 102: 377–379
Vistnes L.M., Lee R., Ksander G.A. Proteolytic activity of blowfly larvae secretions in experimental burns. Surgery 1981; 90: 835–841
Pechter E.A., Sherman R.A. Maggot therapy: the surgical metamorphosis. Plast Reconstr Surg 1983; 72: 567–570
Bunkis J., Gherini S., Walton R.L. Maggot therapy revisited. West J Med 1985; 42: 554–556
Teich S., Myers R.A.M. Maggot therapy for severe skin infections. South Med J 1986; 79: 1153–1155
Stoddard S.R., Sherman R.M., Mason B.A., et al. Maggot debridement therapy: an alternative treatment for nonhealing ulcers. J Am Podiatr Med Ass 1995; 85: 218–221
Sherman R.A., Wyle F., Vulpe M. Maggot therapy for treating pressure ulcers in spinal cord injury patients. J Spinal Cord Med 1996; 18: 71–74
Sherman R.A., My-Tien Tran J., Sullivan, R. Maggot therapy for venous stasis ulcers. Arch Dermatol 1996; 132: 254–256
Mumcuoglu K.Y., Lipo M., Ioffe-Uspensky I, et al. Maggot therapy for gangrene and osteomyelitis [in Hebrew]. Harefuah 1997; 132: 323–325
Mumcuoglu, K.Y., Ingber A., Gilead L. et al. Maggot therapy for the treatment of diabetic foot ulcers. Diabetes Care 1998; 21: 2030–2031
Mumcuoglu K.Y., Ingber A., Gilead L., et al. Maggot therapy for the treatment of intractable wounds. Intl J Dermatol 1999; 38: 623–627
Sherman R.A., Hall M.J.R., Thomas S. Medicinal maggots: an ancient remedy for some contemporary afflictions. Annu Rev Entomol 2000; 45: 55–81
Thomas S., Jones M., Shutler S., et al. Making friends with maggots. Nursing Times 1996; 92: 76–82
Wollf H., Hannson C. Larval therapy for a leg ulcer with methicillin-resistant Staphylococcus aureus. Acta Derm Venereol 1999; 79: 320–321
Russ M., Roesch K., Fleischmann W. Wound treatment with maggots: the Bietigheim experience. Fifth International Conference on Biotherapy; 2000 Jun 29–Jul 1; Wurzburg, 19
Rufli T., Steffen I., Nuesch R., et al. Sepsis as a complication of maggot therapy. Fifth International Conference on Biotherapy; 2000 Jun 29–Jul 1; Wurzburg, 18
Church J.C.T. Biosurgery: larval intervention in the chronic wound. Fifth International Conference on Biotherapy; 2000 Jun 29–Jul 1; Wurzburg, 7
Andrews A., Jones M., Champion A. Larval therapy and wound management. Med Microbiol 1999; 18: 18–19
Simmons S.W. The culture of fly larvae for use in maggot therapy: thesis in zoology and entomology. Iowa State College, Ames: 1938
Weil G.C., Simon R.J., Sweadner W.R. Larval or maggot therapy in the treatment of acute and chronic pyogenic infections. Am J Surgery 1933; 19: 36–48
Sherman R.A., Wyle F.A. Low-cost, low-maintenance rearing of maggots in hospitals, clinics, and schools. Am J Trop Med Hyg 1996; 54: 38–41
Sherman R.A. A new dressing design for treating pressure ulcers with maggot therapy. Plast Reconstruct Surg 1997; 100: 451–456
Fleischmann W., Thoener B. Biobag: a live wound-dressing containing maggots. Fifth International Conference on Biotherapy; 2000 Jun 29–Jul 1; Wurzburg, 8
Sherman RA, Sherman JM-T, Gilead L, et al. Maggot debridement therapy in outpatients. Arch Phys Med Rehab. In press
Jarvis A. Maggots in orthopaedics: past, present and future. Fifth International Conference on Biotherapy; 2000 Jun 29–Jul 1; Wurzburg, 11–12
Robinson W. Ammonium bicarbonate secreted by surgical maggots stimulates healing in purulent wounds. Am J Surgery 1940; 47: 111–115
Robinson W. Stimulation of healing in non-healing wounds by allantoin occurring in maggot secretions and of wide biological distribution. J Bone Joint Surg 1935; 17: 267–271
Courtenay M. Present day experience of larval therapy in the UK. Third International Conference on Biotherapy; 1998 May 24–27; Jerusalem, 9
Messer F.C., McClellan R.H., Pittsburgh M.D. Surgical maggots. A study on their function in wound healing. J Lab Clin Med 1935; 20: 1219–1226
Hobson R.P. On an enzyme from blow-fly larvae (Lucilia sericata) which digests collagen in alkaline solution. Biochem J 1931; 25: 1458–1463
Senior B.W., Graham K., Stevenson J.H. An investigation into the antibacterial properties of maggots in the healing of chronic necrotic ulcers. Third International Conference on Biotherapy; 1998 May 24–27; Jerusalem, 34
Ziffren S.E., Heist H.E., May S.C., et al. The secretion of callagenase by maggots and its implication. Ann Surgery 1957; 138: 932–934
Weil G.C., Simon R.J., Sweadner W.R. A biological, bacteriological and clinical study of larval or maggot therapy in the treatment of acute and chronic pyogenic infections. Am J Surg 1933; 19: 36–48
Simons S.W. The bactericidal properties of excretions of the maggot of Lucilia sericata. Bull Entomol Res 1935; 26: 559–563
Pavillard E.R., Wright E.A. An antibiotic from maggots. Nature 1957; 152: 916–917
Lappin-Scott H.M. Bacterial-maggot interactions in wound therapy. Third International Conference on Biotherapy; 1998 May 24–27; Jerusalem, 21
Thomas S., Andrews A.M., Hay N.P., et al. The anti-microbial activity of maggot secretions: results of a preliminary study. J Tissue Viability 1999: 9: 127–132
Robinson W., Norwood V.H. Destruction of pyogenic bacteria in the alimentary tract of surgical maggots implanted in infected wounds. J Lab Clin Med 1934; 19: 581–586
Mumcuoglu KY, Miller J, Mumcuoglu M, et al. Destruction of bacteria in the digestive tract of the maggot of Lucilia sericata. J Med Entomol. In press)
Friedman E., Shaharabany M., Ravin S., et al. Partially purified antibacterial agent from maggots displays a wide range of antimicrobial activity. Third International Conference on Biotherapy; 1998 May 24–27; Jerusalem, 14
Harris P. Enzymes in secretions of maggots. Forth International Biotherapy Conference; 1999 Jun 10–11; Porthcawl, South Wales, 9
Greenberg B. Model for destruction of bacteria in the midgut of blow fly maggots. J Med Entomol 1968; 5: 31–38
Espinoza-Fuentes F.P., Terra W.R. Physiological adaptations for digesting bacteria. Water fluxes and distribution of digestive enzymes in Musca domestica larval midgut. Insect Biochem 1987; 17: 809–817
Robinson W. Use of urea to stimulate healing in chronic purulent wounds. Am J Surgery 1936; 33: 192–197
Livingston S.K. The therapeutic active principle of maggots. J Bone Joint Surg 1936; 18: 751–756
Robinson W. Some therapeutic uses of insects and their products. J Econ Entomol 1937; 30: 41–48
Robinson W., Baker F.L. The enzyme urease and occurrence of ammonia in maggot infected wounds. J Parasitol 1939; 25: 149–155
Mumcuoglu K.Y., Miller J., Ioffe-Uspensky I., et al. The potential of maggots to secrete cytokines in vitro. Fifth International Conference on Biotherapy; 2000 Jun 29–Jul 1; Wurzburg, 14–15
Wollina U., Liebold K., Schmidt W., et al. Biosurgery supports granulation and debridement and improves oxygen supply in chronic wounds. Fifth International Conference on Biotherapy; 2000 Jun 29–Jul 1; Wurzburg, 24
Reames M.K., Christensen C., Luce E.A. The use of maggots in wound debridement. Ann Plastic Surg 1988; 21: 1–4
Teich S., Myers R.A.M.. Maggot therapy for severe skin infections. South Med J 1986; 79: 1153–1155
Acknowledgements
I thank Drs Jacqueline Miller and Ronald Sherman for their critical review of this manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mumcuoglu, K.Y. Clinical Applications for Maggots in Wound Care. Am J Clin Dermatol 2, 219–227 (2001). https://doi.org/10.2165/00128071-200102040-00003
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128071-200102040-00003